80wk Downtrend — falling+below (sma 7.57 vs px 3.65)
200wk Downtrend — falling+below (sma 10.17 vs px 3.65)
Short Attack — velZ +82.80 · age 13w×1.00 · 0.51%
Earnings Headwind — ER in 27.476d · w1 med -2.9% (mag 1/3) · winRate 18.2% (rel 3/3) · n22
RS Breakdown — momZ +0.70 · low 0w×1.00 · vs industry
About Addex Therapeutics Ltd
Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant, which is in phase 1 clinical trial for the treatment of post-stroke/TBI recovery, as well as to treat Parkinson's disease levodopa-induced dyskinesia. Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: January 29, 2020
Headquarters: Chemin des Mines, 9, Geneva, Switzerland, 1202
Founder-Led: Yes — Tim Dyer (Co-Founder, CEO & Director), Roger Gomis (Chief Medical Officer & Director)
Key Metrics
Current Price
$3.04
Market Cap
$5.6M
Float
1.2M
Shares Outstanding
1.8M
Price/Sales (TTM)
67.09
vs. Analyst Target
+886.8% to analyst PT
Operating Margin (TTM)
-6487.25%
Revenue (TTM)
$83,069
Dividend Rate
None
Analyst Target Price
$30.00
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
$3.6M
-$12.9M
$3.6M
-$12.4M
2021
$2.9M
-$15.4M
$2.9M
-$14.9M
2022
$1.4M
-$20.8M
$1.4M
-$10.5M
2023
$1.6M
-$10.6M
$1.6M
-$2.2M
2024
$404,102
$7.1M
$404,102
-$4.6M
2025
$29,972
-$6.7M
$29,972
-$6.8M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Sep 2025
$29,724
-$1.6M
Dec 2025
$19,806
-$2.3M
Mar 2026
$7,691
-$1.7M
Jun 2026
$9,908
-$1.7M
Ownership & Float
Institutional Ownership
0.0%
Short Float
0.3%
% of All Funds Holding
0.02%
Number of Funds Holding
2
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$3.83
Near-term / short-term trend
Weekly
40-Week SMA
$5.95
Medium-term trend
Weekly
80-Week SMA
$7.23
Cyclical trend (business cycle)
Weekly
200-Week SMA
$9.82
Secular trend (multi-year)
Monthly
10-Month SMA
$5.55
Near-term monthly trend
Monthly
20-Month SMA
$6.90
Medium-term monthly trend
Monthly
40-Month SMA
$7.79
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$5.20
resistance
9.07x
1 months ago
Historical Earnings Reactions (23 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
-1.27%
-1.79%
21.74%
3.99%
-8.72%
1 Day
-1.33%
-0.69%
30.43%
7.10%
-10.97%
1 Week
-3.24%
-2.53%
21.74%
25.93%
-23.19%
2 Weeks
-8.29%
-6.03%
27.27%
12.06%
-57.30%
1 Month
-10.01%
-6.11%
18.18%
31.87%
-58.42%
Next earnings: December 3, 2026 (51 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Insufficient historical data for monthly seasonality analysis (requires 7+ years of data).
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
-1.31%
38.1%
312
Tuesday
-0.04%
39.0%
346
Wednesday
0.14%
41.6%
344
Thursday
0.68%
42.4%
337
Friday
0.50%
42.8%
334
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 0.0%
Insider Transactions — Smart Summary
Founder-led management: Tim Dyer (Co-Founder, CEO & Director), Roger Gomis (Chief Medical Officer & Director)
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Addex Therapeutics Ltd
(ADXN) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.